ClinicalTrials HQ

PREventing Second Cancers With DOSTARlimab

PREventing Second Cancers With DOSTARlimab

Recruiting · NCT05855811 · Registry updated 2024-07-15
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
PREventing Second Cancers With DOSTARlimabCancer, Second Primary, Disease Attributes, Neoplasms, Second Primary, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, neoplasmRecruitingPhase 22024-07-15NCT05855811

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Centre Leon Berard67
GlaxoSmithKline294

5 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre François BaclesseCaenFrance39
Centre Jean PerrinClermont-FerrandFrance37
Centre Léon BérardLyonFrance50
Institut Claudius RegaudToulouseFrance13
Institut Gustave RoussyVillejuifFrance58